相关实验视频
Updated: Jul 20, 2026
11:11
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
Published on: August 24, 2017
16.8K
循环瘤DNA:当前的实施问题和临床实用性的未来挑战
Qilin Hu1, Lujun Chen2, Kerui Li1
1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, P.R. China.
Clinical chemistry and laboratory medicine
|December 18, 2023
概括
使用循环瘤DNA (ctDNA) 的液体活检显示了癌症治疗的前景. 需要进一步的研究和临床研究来克服挑战,并将这些先进的非侵入性测试完全纳入瘤学决策.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 基因组学就是基因组学.
背景情况:
- 液体活检,特别是循环瘤DNA (ctDNA),是一种用于癌症检测和监测的非侵入性方法.
- 下一代测序和人工智能的进步提高了液体活检的准确性和灵敏度,特别是在固体瘤中.
研究的目的:
- 为ctDNA技术和临床应用提出一个概念框架.
- 突出临床瘤学中ctDNA的挑战和未来方向.
主要方法:
- 对ctDNA技术和临床实用工具的图书统计分析.
- 对癌症中ctDNA应用的当前文献的综述.
主要成果:
- ctDNA具有早期癌症诊断,复发检测,治疗监测和理解耐药性的巨大潜力.
- 将ctDNA测试整合到临床决策中面临着复杂性和挑战.
结论:
- 严格的临床研究和翻译研究对于支持治疗策略决策过程至关重要.
- 未来的方向包括加强ctDNA在早期检测中的作用,最小残留疾病监测,向治疗和免疫治疗.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...